Literature DB >> 27574350

Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma.

Mihaela Vlad1, Ioana Zosin1, Bogdan Timar2, Fulger Lazar3, Adrian Vlad4, Romulus Timar4, Marioara Cornianu5.   

Abstract

Medullary thyroid carcinoma (MTC) is a rare form of malignancy, having an intermediate prognosis. Controversies exist regarding the best surgical approach. The aim of the study was to analyze the outcome in a group of patients with MTC, diagnosed and followed up in a single care center. We performed a retrospective analysis of all the patients diagnosed with MTC in the Department of Endocrinology from the County Emergency Hospital Timisoara between 1992 and 2012. The study group included 19 patients, 6 men (31.6 %), mean age 41.2 ± 12.5 years (20-72 years). The preoperative diagnosis was based on the protocol for nodular thyroid disease. Total or near-total thyroidectomy was performed in 10 out of 16 patients who could be operated. Postoperative follow-up included repeated measurements of serum calcitonin and imaging investigations. Nine out of the total of 19 (47.3 %) patients had hereditary forms of MTC. Most of the cases (84.2 %) were submitted to surgery. The median duration of follow-up was 84 months. The pTNM staging indicated that the majority of the patients with hereditary MTC were diagnosed in an earlier stage. Disease remission was achieved in 7 cases (43.8 %). Four patients, all with sporadic forms, died. Survival rates at 1, 5 and 10 years were significantly higher (p = 0.048) in patients with hereditary MTC. An early diagnosis of MTC allows a better surgical approach and an improved survival rate. We support the general recommendation that modified radical neck dissection is not necessary for all the patients with MTC.

Entities:  

Keywords:  Medullary thyroid carcinoma; Modified radical neck dissection; Multiple endocrine neoplasia; Prognosis; Total thyroidectomy

Year:  2015        PMID: 27574350      PMCID: PMC4987558          DOI: 10.1007/s12262-015-1386-5

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  19 in total

1.  Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone.

Authors:  Jong-Lyel Roh; Jae-Yong Park; Chan Il Park
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

2.  Prognostic variables and calcitonin in medullary thyroid cancer.

Authors:  Jonathan R Clark; Tauba R Fridman; Michael J Odell; James Brierley; Paul G Walfish; Jeremy L Freeman
Journal:  Laryngoscope       Date:  2005-08       Impact factor: 3.325

3.  2012 European thyroid association guidelines for metastatic medullary thyroid cancer.

Authors:  M Schlumberger; L Bastholt; H Dralle; B Jarzab; F Pacini; J W A Smit
Journal:  Eur Thyroid J       Date:  2012-03-28

4.  Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.

Authors:  E Kebebew; P H Ituarte; A E Siperstein; Q Y Duh; O H Clark
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

5.  Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.

Authors:  Tina W F Yen; Suzanne E Shapiro; Robert F Gagel; Steven I Sherman; Jeffrey E Lee; Douglas B Evans
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

6.  Need for a revised staging consensus in medullary thyroid carcinoma.

Authors:  Sarah Y Boostrom; Clive S Grant; Geoffrey B Thompson; David R Farley; Melanie L Richards; Tanya L Hoskin; Ian D Hay
Journal:  Arch Surg       Date:  2009-07

7.  Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.

Authors:  Simona Grozinsky-Glasberg; Carlos A Benbassat; Gloria Tsvetov; Rafael Feinmesser; Hava Peretz; Ilan Shimon; Mordechai Lapidot
Journal:  Thyroid       Date:  2007-06       Impact factor: 6.568

8.  Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.

Authors:  M E Dottorini; A Assi; M Sironi; G Sangalli; G Spreafico; L Colombo
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

9.  The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies.

Authors:  Kai-Pun Wong; Brian Hung-Hin Lang
Journal:  J Oncol       Date:  2011-09-29       Impact factor: 4.375

10.  Clinical comments related to medullary thyroid cancer diagnosis and management.

Authors:  Leonidas H Duntas
Journal:  Thyroid Res       Date:  2013-03-14
View more
  1 in total

1.  What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.

Authors:  Denise Garcia; Julie B Siegel; David A Mahvi; Biqi Zhang; David M Mahvi; E Ramsay Camp; Whitney Graybill; Stephen J Savage; Antonio Giordano; Sara Giordano; Denise Carneiro-Pla; Mahsa Javid; Aaron P Lesher; Andrea Abbott; Nancy Klauber DeMore
Journal:  Clin Oncol Res       Date:  2020-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.